Drug Delivery Systems Targeting the Knee Microenvironment: A Prospective Strategy for Knee Osteoarthritis Treatment

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Orthopedics

Background:

• Knee osteoarthritis (KOA) is a degenerative joint disease causing cartilage deterioration, inflammation, and pain.
• Current KOA treatments, including intra-articular (IA) injections, often face limitations like poor drug bioavailability and systemic side effects.
• The knee joint's microenvironment is critical for effective drug delivery, especially for intra-articular therapies.

Purpose of the Study:

• To review recent advancements in nanotechnology-based drug delivery systems for KOA.
• To explore how these systems can overcome the limitations of traditional KOA treatments.
• To discuss future directions for optimizing KOA therapy through innovative drug delivery.

Main Methods:

• Literature review of current research on nanotechnology applications in KOA treatment.
• Analysis of drug delivery systems (DDS) focusing on the knee joint's microenvironment.
• Examination of the advantages of nanotechnology, including targeted delivery and reduced toxicity.

Main Results:

• Nanotechnology-based DDS show promise for precise targeting and minimizing systemic toxicity in KOA treatment.
• These advanced systems can potentially improve drug bioavailability and therapeutic effects within the knee joint.
• Understanding the knee's microenvironment is key to developing more effective drug delivery strategies.

Conclusions:

• Nanotechnology-based therapies represent a significant advancement in managing knee osteoarthritis.
• Optimized drug delivery systems are crucial for enhancing treatment efficacy and patient outcomes in KOA.
• Further research into nano-therapies and knee joint interactions will refine future KOA treatment strategies.